GSK submits sNDA for Promacta to FDA for severe aplastic anaemia treatment - 0 views
-
Alex Parker on 04 Mar 14GSK submits sNDA for Promacta to FDA for severe aplastic anaemia treatment
Group items tagged
Child Therapy Works - 2 views
I have the chance of asking professional help for my kid who has been depressed for the past few weeks. We did not know what the reason was and so we asked help from NLP4Kids a reputed therapy orga...
Surgical Removal of Testis or Orchidectomy | Medindia - 0 views
-
Slide animation describing the surgical procedure for Removal of one or both Testis (Orchiectomy) that is done for prostate cancer, torsion testis or testicular tumor.
Drug Therapy for Inherited Kidney Disease on the Anvil | MedIndia - 0 views
-
Patients with an inherited kidney disease may be helped by a drug that is currently available for other uses, scientists at UC Santa Barbara have discovered.
High Dosage Of Vitamin D3 Safe For Obese Adolescents | MedIndia - 0 views
-
High dosage of vitamin D3 is safe for obese adolescents, say University of Missouri researchers.
Chin and Abdomen Examination Best To Check For Excessive Hair Growth In Women | MedIndia - 0 views
-
Examining the chin and upper and lower abdomen could be the most reliable and minimally invasive way to screen for excessive hair growth in women.
Bristol-Myers Squibb gets FDA breakthrough designation for daclatasvir-based regimen - 0 views
-
PBR Staff Writer Published 25 February 2014 Bristol-Myers Squibb (BMS) has received Breakthrough Therapy Designation from the US Food and Drug Administration (FDA) for its investigational DCV Dual Regimen (daclatasvir and asunaprevir) for use as a combination therapy in the treatment of genotype 1b chronic hepatitis C infection (HCV).
Pluristem files orphan drug application to US FDA for preeclampsia - 0 views
-
PBR Staff Writer Published 21 February 2014 Israel-based Pluristem Therapeutics has submitted its application to the US Food and Drug Administration seeking Orphan Drug Designation for its PLacental eXpanded (PLX-PAD) cells for the treatment of severe preeclampsia.
Vertex gets FDA approval for Kalydeco sNDA - 0 views
-
PBR Staff Writer Published 24 February 2014 US-based biotechnology firm Vertex Pharmaceuticals has received approval from the US Food and Drug Administration (FDA) for a supplemental New Drug Application (sNDA) of its Kalydeco (ivacaftor) for the treatment of people with cystic fibrosis (CF).
KYTHERA files NDA for ATX-101 to reduce unwanted submental fat - 1 views
-
US-based KYTHERA Biopharmaceuticals has submitted a new drug application (NDA) to the US Food and Drug Administration (FDA) for ATX-101 (deoxycholic acid) as an injectable treatment for the reduction of submental fat, which commonly presents as a double chin.
Goodwin, Aspyrian partner for cGMP manufacturing of new antibody drug conjugate - 1 views
-
PBR Staff Writer Published 25 March 2014 US-based Goodwin Biotechnology has entered into an agreement with Aspyrian Therapeutics for the technology transfer, process development, scale-up, and cGMP manufacturing of a new Antibody Drug Conjugate (ADC) for use in Phase I clinical trials.
Prevention Cream For Stretch Marks - 1 views
I was really afraid to get pregnant because I knew then that my skin will be prone to stretch marks. That is why I have researched on How to get rid of stretch marks to prevent it from appearing o...
Malaria- A Review of Recent Guidelines in the Indian Context | MedIndia - 0 views
-
Microscopy of blood smears remains the gold standard for confirmation of diagnosis of malaria.
One Step Closer To Your Dreams - 1 views
The trains and railways provide speed and ease to travelling passengers. I love trains and that motivates me to Become a train driver. I really want to drive a train myself. I want to take every ...
Losing Weight Through Professional Help - 0 views
It is not easy being an obese because you always become the subject of ridicule. It is for this reason that I really exerted enough efforts going to the gym in order to lose weight. Yet, I did not ...
Epic Sciences partners with LabCorp for circulating tumor cell technology - 0 views
-
Epic Sciences has announced an agreement with Laboratory Corporation of America Holdings (LabCorp) to expedite sample processing for Epic's circulating tumor cell (CTC) technology to support European clinical trials.
OctreoPharm's OPS202 gets EMA orphan drug designation for management of GEP-NETs - 0 views
-
Germany-based OctreoPharm Sciences has received Orphan Drug Designation from the European Medicines Agency (EMA) for OPS202 as a diagnostic agent for the management of patients with gastro-entero-pancreatic-neuroendocrine tumors
Aegis awarded its first patent for oral delivery of nucleotide-based drugs - 0 views
-
Aegis Therapeutics has been awarded its first patent for oral delivery of nucleotide analog based drugs based upon the company's patented Intravail transmucosal absorption enhancer technology
Perrigo buys OTC products from Aspen Global for $51m - 1 views
-
Ireland-based Perrigo Company has acquired a basket of value-brand OTC products sold in Australia and New Zealand from Aspen Global for $51m.
Oramed gets third Australia patent for oral Exenatide - 1 views
-
Israel-based clinical-stage pharmaceutical firm Oramed Pharmaceuticals has received its third patent in Australia for oral administration of exenatide from the Australian government's patent office 'IP Australia'.